Publication | Open Access

A multi-centre, double-blind, placebo-controlled study of liposomal prostaglandin E1 (TLC C-53) in patients with acute respiratory distress syndrome

AsthmaInflammationAcute Lung InjuryInflammatory MarkerSepsisPlacebo-controlled StudyLiposomal Prostaglandin E1Acute MedicineMedicinePulmonary DiseaseEmergency MedicineTlc C-53